KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLoans - NetMinority InterestOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReal Estate - GrossReal Estate - NetReceivablesReceivables - AccuredShareholder's EquityTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Realty Trust (HR) Liabilities and Shareholders Equity (2016 - 2025)

Healthcare Realty Trust (HR) has 16 years of Liabilities and Shareholders Equity data on record, last reported at $9.2 billion in Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity fell 13.52% year-over-year to $9.2 billion; the TTM value through Dec 2025 reached $19.1 billion, down 15.07%, while the annual FY2025 figure was $9.2 billion, 13.52% down from the prior year.
  • Liabilities and Shareholders Equity reached $9.2 billion in Q4 2025 per HR's latest filing, down from $9.9 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $13.8 billion in Q4 2022 and bottomed at $4.3 billion in Q4 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $9.8 billion, with a median of $10.3 billion recorded in 2024.
  • Peak YoY movement for Liabilities and Shareholders Equity: tumbled 37.28% in 2021, then skyrocketed 225.19% in 2022.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $4.3 billion in 2021, then surged by 225.19% to $13.8 billion in 2022, then dropped by 8.75% to $12.6 billion in 2023, then dropped by 15.72% to $10.7 billion in 2024, then decreased by 13.52% to $9.2 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $9.2 billion in Q4 2025, $9.9 billion in Q3 2025, and $10.7 billion in Q4 2024.